noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

SAMHSA - Substance Abuse and Mental Health Services Administration

01/17/2025 | Press release | Distributed by Public on 01/17/2025 16:10

DEA and HHS Issue Final Telemedicine Rule for Buprenorphine Access

January 17, 2025

The Drug Enforcement Administration (DEA), together with the Department of Health and Human Services (HHS), finalized telemedicine flexibility regulations for the prescribing of medications for opioid use disorder, including buprenorphine.

This final rule makes permanent the buprenorphine-related telemedicine flexibilities that DEA and HHS had extended through the end of 2025.

Learn more at Buprenorphine Telemedicine Prescribing: Questions and Answers.

SAMHSA - Substance Abuse and Mental Health Services Administration published this content on January 17, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on January 17, 2025 at 22:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format